A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine

Biomarkers to guide antibiotic treatment decisions have been proposed as an effective way to enhancing a more appropriate use of antibiotics. As a biomarker, procalcitonin (PCT) has been found to have good specificity to distinguish bacterial from non-bacterial inflammations. Decisions regarding ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzini, Anna Maria, Dorizzi, Romolo Marco, Sette, Piersandro, Vecchi, Marta, Coledan, Ilaria, Righi, Elda, Tacconelli, Evelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Advances in Laboratory Tests for Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290560/
https://www.ncbi.nlm.nih.gov/pubmed/32566636
http://dx.doi.org/10.21037/atm-20-1855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290560/
https://www.ncbi.nlm.nih.gov/pubmed/32566636
http://dx.doi.org/10.21037/atm-20-1855

Ejemplares similares